The Drive

Special episode — Obicetrapib: The CETP inhibitor with cardiovascular benefits and potential Alzheimer's prevention

This episode discusses obicetrapib, an investigational drug that acts as a CETP inhibitor. It covers the history of CETP inhibitors, their effects on cardiovascular risk factors, and potential implications for Alzheimer's disease based on emerging biomarker evidence.

Listen